Assessment of GFR: Chemical techniques and prediction equations

Functional Imaging in Nephro-Urology

Volumn , Issue , 2006, Pages 11-18

  Nally, Joseph V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052034590     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39(Suppl 2): S1-246.
2. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis and renal biopsy. In: Brenner BM, Rector FC (eds). The Kidney, Vol. 1, 6th edn. Philadelphia: WB Saunders, 2000: 1129-70.
3. Levey AS. Use of glomerular filtration rate measurements to assess the progression of renal disease. Semin Nephrol 1989; 9: 370-9.
4. Florijn KW, Barendregt JN, Lentjes EG et al. Glomerular filtration rate measurement by 'single-shot' injection of inulin. Kidney Int 1994; 46: 252-9.
5. Blaufox MD, Aurell M, Bubeck B et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996; 37: 1883-90.
6. Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int Suppl 1994; 47: S17-S19.
7. Brandstrom E, Grzegorczyk A, Jacobsson L et al. GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-82.
8. Brown SCW, O'Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard. J Urol 1991; 146: 675-9.
9. Brochner-Mortensen J, Jensen S, Rodbro P. Delimitation of plasma creatinine concentration values for assessment of relative renal function in adult patients. Scand J Urol Nephrol 1977; 11: 257-62.
10. Sterner G, Frennby B, Hultberg B, Almen T. Iohexol clearance for GFR-determination in renal failure - single or multiple plasma sampling? Nephrol Dial Transplant 1996; 11: 521-5.
11. Gaspari F, Perico N, Matalone M et al. Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol 1998; 9: 310-13.
12. Houlihan C, Jenkins M, Osicka T et al. A comparison of the plasma disappearance of iohexol and 99mTc-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes. Aust NZ J Med 1999; 29: 693-700.
13. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167-84.
14. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
15. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
16. Coresh J, Toto RD, Kirk KA et al. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis 1998; 32: 32-42.
17. Ross JW, Miller WG, Myers GL, Praestgaard J. The accuracy of laboratory measurements in clinical chemistry: a study of 1 1 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch Pathol Lab Med 1998; 122: 587-608.
18. Miller WG, Myers GL, Ashwood ER et al. Creatinine measurement: State of the art in accuracy and interlaboratory harmonizations. Arch Pathol Lab Med 2005; 129: 297-304.
19. Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998; 32: 23-31.
20. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48: 699-707.
21. Newman DJ, Thakkar H, Edwards RG et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-18.
22. Finney H, Newman DJ, Gruber W et al. Initial evaluation of cystatin C measurement by particle-enhanced immunoneph-elometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43(Pt 1): 1016-22.
23. Herget-Rosenthal S, Trabold S, Pietruck F et al. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000; 20: 97-102.
24. Schwartz GJ, Haycock GB, Edelmann CM Jr., Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-63.
25. Counahan R, Chantler C, Ghazali S et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 1976; 51: 875-8.
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
27. Poggio ED, Wang X, Greene T et al. Performance of the MDRD and Cockcroft-Gault equations in the estimation of glomerular filtration rate in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-66.
28. Weinstein DM, Augustine JJ, Poggio ED et al. Reliability of the MDRD equation and Cockcroft-Gault in estimating glomerular filtration rate in kidney transplant patients [Abstract]. J Am Soc Nephrol 2003; 14: 435A.
29. Poggio ED, Nef PC, Wong X et al. Performance of the Cockcroft-Gault and MDRD equations in estimating GFR in ill hospitalized patients. Am Kid Dis 2005; 46: 242-52.
30. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD, for the Collaborative Study Group. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
31. Parving HH, Lehnert H, Brochner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-8.
32. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004; 351: 1344-6.
33. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.